References
- Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357(9274):2122–8.
- Gritti P, Sgarzi M, Carrara B, A standardized protocol for the perioperative management of myasthenia gravis patients. Experience with 110 patients. Acta Anaesthesiol Scand 2012;56(1):66–75.
- Jani-Acsadi A, Lisak RP. Myasthenia gravis. Curr Treat Options Neurol 2010;12(3):231–43.
- Lacomis D. Myasthenic crisis. Neurocrit Care 2005;3(3): 189–94.
- Nam TS, Lee SH, Kim BC, Clinical characteristics and predictive factors of myasthenic crisis after thymectomy. J Clin Neurosci 2011;18(9):1185–8.
- Watanabe A, Watanabe T, Obama T, Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 2004; 127(3):868–76.
- Thomas CE, Mayer SA, Gungor Y, Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 1997;48(5):1253–60.
- Soleimani A, Moayyeri A, Akhondzadeh S, BMC Neurol 2004;4(1):12.
- Barohn RJ. Standards of measurements in myasthenia gravis. Ann N Y Acad Sci 2003;998:432–9.
- Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann N Y Acad Sci 1981; 377:670–7.
- Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol 2004;24(1):17–20.
- Jani-Acsadi A, Lisak RP. Myasthenic crisis: guidelines for prevention and treatment. J Neurol Sci 2007;261(1–2):127–33.
- Christensson B, Biberfeld P, Matell G. B-cell compartment in the thymus of patients with myasthenia gravis and control subjects. Ann N Y Acad Sci 1988;540:293–7.
- Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55(1):7–15.
- Marx A, Pfister F, Schalke B, et al. Thymus pathology observed in the MGTX trial. Ann N Y Acad Sci 2012;1275:92–100.
- Juel VC, Massey JM. Myasthenia gravis. Orphanet J Rare Dis 2007;2(1):44.
- Liu WB, Men LN, et al. Prognostic factors of myasthenic crisis after extended thymectomy in patients with generalized myasthenia gravis. Zhonghua Yi Xue Za Zhi. 2006;86(39):2737–40.
- Chu XY, Xue ZQ, Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy. Chin Med J (Engl) 2011;124(8):1246–50.
- Koinuma T, Nunomiya S, Wada M, et al. Predictive analysis for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. Masui 2012;61(2):170–6.
- Panda S, Goyal V, Behari M, et al. Myasthenic crisis: a retrospective study. Neurol India 2004;52(4):453–6.
- Zhang X, Yang M, Xu J, Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry 2006;78(4):386–90.
- Huang YC, Yeh JH, Chiu HC, Chen WH. Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan. J Formos Med Assoc 2008;107(7):572–5.
- Yang L, Maxwell S, Leite MI, Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China. J Neurol Sci 2011;301(1–2): 71–6.